Rare diseases
Investigational molecules
Locations
Study on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors
FranceStudy of Palbociclib as an Alternative to Chemotherapy for Older Patients with High-Risk Early Breast Cancer
FranceStudy of pembrolizumab and vorinostat combination therapy in patients with recurrent or metastatic squamous cell carcinoma of head and neck, cervix, anus, and genital areas
FranceStudy on Talquetamab and Tocilizumab for Patients with Relapsed or Refractory Multiple Myeloma
FranceStudy on the Effectiveness and Safety of Crovalimab for Children with Atypical Hemolytic Uremic Syndrome (aHUS)
FranceStudy on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment
FranceStudy of Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Renal Cell Carcinoma
FranceStudy of ALX148 with Trastuzumab, Ramucirumab, and Paclitaxel for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
FranceStudy of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy
FranceStudy of Tobemstomig with Platinum-Based Chemotherapy vs Pembrolizumab with Platinum-Based Chemotherapy for Untreated Non-Small Cell Lung Cancer Patients
FranceStudy on the Effects of Bexotegrast for Patients with Idiopathic Pulmonary Fibrosis
FranceStudy on Aficamten for Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
